Skip to content

SOLAE BELGIUM

Active
Public limited companyfounded 197749 yrs activeZwaanhofweg 1, 8900 Ieper, BelgiumKBO/BCE: BE 0416.815.235
Summary

SOLAE BELGIUM has been active since 1977 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €31.38M and a net result of €1.09M. Equity is growing by ~4.1% per year across the filed fiscal years. Its solvency ranks better than 89% of 643 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
82 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▼-5
Solvency100▲+3
Growth38▼-18
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity ample (current ratio 2.25 against 1.75 in 2024; short-term debt: 18.8% and cash: 11.2% of total assets), and 19.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 49 years 0 50 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
80.9%
Return on assets
2.8%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 10
Relative position
BE, all sectors
reference
Sector 10
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-06-2026, 53 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
53 d early
2024
71 d early
2023
64 d early
2022
55 d early
2021
54 d early
2020
65 d early
2019
49 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€38.43M▼ 2.5%
2024 · €39.42M
2018: €28.13M 2019: €28.32M 2020: €28.06M 2021: €37.74M 2022: €45.19M 2023: €45.09M 2024: €39.42M
2018 → 2025
EBIT margin
4.1%▼ 2.2pp
2024 · 6.2%
2018: 5.5% 2019: 6.3% 2020: 6.2% 2021: 4.4% 2022: 4.7% 2023: 4.4% 2024: 6.2%
2018 → 2025
Net result
€1.09M▼ 45.8%
2024 · €2.01M
2018: €1.14M 2019: €1.21M 2020: €1.18M 2021: €1.17M 2022: €1.54M 2023: €1.62M 2024: €2.01M
2018 → 2025
Working capital
€9.10M▲ 4.5%
2024 · €8.70M
2018: €11.96M 2019: €14.39M 2020: €4.15M 2021: €5.04M 2022: €6.57M 2023: €8.57M 2024: €8.70M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€37.74M-€45.19M▲ 19.7%€45.09M▼ 0.2%€39.42M▼ 12.6%€38.43M▼ 2.5%
Equity€25.12M-€26.66M▲ 6.1%€28.28M▲ 6.1%€30.29M▲ 7.1%€31.38M▲ 3.6%
Operating result€1.68M-€2.11M▲ 25.9%€1.98M▼ 6.3%€2.46M▲ 24.0%€1.57M▼ 36.2%
Net result€1.17M-€1.54M▲ 31.3%€1.62M▲ 5.8%€2.01M▲ 23.7%€1.09M▼ 45.8%
Result per fiscal year
Operating resultNet result
€0€1.00M€2.00MOperating result 2021: €1.68M€1.68MNet result 2021: €1.17M€1.17MOperating result 2022: €2.11M€2.11MNet result 2022: €1.54M€1.54MOperating result 2023: €1.98M€1.98MNet result 2023: €1.62M€1.62MOperating result 2024: €2.46M€2.46MNet result 2024: €2.01M€2.01MOperating result 2025: €1.57M€1.57MNet result 2025: €1.09M€1.09M20212022202320242025€0€1M€2MOperating result 2023: €1.98M€2MNet result 2023: €1.62M€1.6MOperating result 2024: €2.46M€2.5MNet result 2024: €2.01M€2MOperating result 2025: €1.57M€1.6MNet result 2025: €1.09M€1.1M202320242025
The operating result falls in 2025; 2025 is 36% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €38.76M
Fixed assets €22.38M ▲ 3.2%
Current assets €16.38M ▼ 19.6%
Equity and liabilities €38.76M
Equity €31.38M ▲ 3.6%
Provisions €78k ▼ 0.1%
Debt €7.31M ▼ 37.5%
Debt's share of the balance-sheet total falls from 27.8% to 18.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€5.58M
2024 · €6.51M
Cash flow
€5.10M
2024 · €6.07M
Current ratio
2.25
2024 · 1.75
Quick ratio
1.81
2024 · 1.50
Debt to equity
0.23
2024 · 0.39
ROE
3.5%
2024 · 6.6%
ROA
2.8%
2024 · 4.8%
Interest coverage
18405.10
2024 · 10606.60
Debt ≤ 1 year
€7.29M
2024 · €11.67M
Income taxes
€284k
2024 · €748k
Staff costs
€8.44M
2024 · €8.00M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 68 lines
Balance sheet Code20242025
Assets
Total assets20/58€42.06M€38.76M
Fixed assets21/28€21.69M€22.38M
Intangible fixed assets21€123k€61k
Tangible fixed assets22/27€21.57M€22.32M
Land and buildings22€1.99M€2.67M
Plant, machinery and equipment23€14.69M€13.86M
Assets under construction and advance payments27€4.89M€5.78M
Financial fixed assets28€2k€2k=
Other financial fixed assets284/8€2k€2k=
Amounts receivable and cash guarantees285/8€2k€2k=
Current assets29/58€20.37M€16.38M
Stocks and contracts in progress3€2.85M€3.20M
Stocks30/36€2.85M€3.20M
Raw materials and consumables30/31€2.85M€3.20M
Amounts receivable within one year40/41€1.87M€7.32M
Trade receivables40€725k€6.11M
Other amounts receivable41€1.15M€1.21M
Cash at bank and in hand54/58€13.48M€4.32M
Deferred charges and accrued income490/1€2.17M€1.55M
Equity and liabilities
Total equity and liabilities10/49€42.06M€38.76M
Equity10/15€30.29M€31.38M
Contributions10/11€20.10M€20.10M=
Capital10€20.10M€20.10M=
Issued capital100€20.10M€20.10M=
Reserves13€2.63M€2.63M=
Non-distributable reserves130/1€2.01M€2.01M=
Legal reserve130€2.01M€2.01M=
Distributable reserves133€621k€621k=
Profit (loss) carried forward14€7.52M€8.61M
Investment grants15€38k€38k
Provisions and deferred taxes16€78k€78k
Deferred taxes168€78k€78k
Amounts payable17/49€11.70M€7.31M
Amounts payable within one year42/48€11.67M€7.29M
Trade debts44€9.86M€5.73M
Suppliers440/4€9.86M€5.73M
Taxes, remuneration and social security45€1.81M€1.56M
Taxes450/3€266k€257k
Remuneration and social security454/9€1.54M€1.30M
Accrued charges and deferred income492/3€33k€24k
Income statement Code20242025
Operating income70/76A€39.46M€38.47M
Turnover70€39.42M€38.43M
Other operating income74€44k€32k
Operating charges60/66A€37.01M€36.90M
Goods for resale, raw materials and consumables60€1.69M€1.56M
Purchases600/8€1.82M€1.63M
Change in stocks: decrease (increase)609€-129k€-66k
Services and other goods61€21.41M€20.87M
Remuneration, social security and pensions62€8.00M€8.44M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4.06M€4.01M
Other operating charges640/8€1.85M€2.02M
Operating profit (loss)9901€2.46M€1.57M
Financial income75/76B€319k€383k
Recurring financial income75€319k€383k
Other financial income752/9€319k€383k
Financial charges65/66B€17k€576k
Recurring financial charges65€17k€576k
Debt charges650€614€303
Other financial charges652/9€17k€576k
Profit (loss) for the period before taxes9903€2.76M€1.37M
Transfer from deferred taxes780€97€57
Income taxes67/77€748k€284k
Taxes670/3€748k€284k
Profit (loss) for the period9904€2.01M€1.09M
Profit (loss) for the period to be appropriated9905€2.01M€1.09M
Appropriation of the result
Profit (loss) to be appropriated9906€7.52M€8.61M
Profit (loss) brought forward from the previous period14P€5.51M€7.52M
Social balance
Average headcount (FTE)908783.783.7=

The notes to these accounts (52 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
08-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial Weakest financial yearnet €1.09M ▼45.8%
Net result drops to €1.09M, the lowest in the series.
12-11
State Gazette act Resignation: Wim Stragier (director)
Appointment: Laszlo Karger-Kocsis (director) · Mandate compensation · Power of attorney8 facts ▸
  • General meeting, 14-03-2025
  • Director resignation, Wim Stragier (director)
  • Director appointment, Laszlo Karger-Kocsis (director)
  • Mandate compensation, Laszlo Karger-Kocsis
  • Board composition, Jeroen Ingelbrecht (director)
  • Board composition, Filip Pauwels (director)
  • Board composition, Laszlo Karger-Kocsis (director)
  • Power of attorney, DLA Piper UK LLP
21-05
NBB filing Annual accounts filed
fiscal year 2024 · full schema
02-01
State Gazette act Permanent representatives: Filip Drieghe and Wouter Coppens
2 facts ▸
  • Permanent representative, Filip Drieghe
  • Permanent representative, Wouter Coppens
2024
31-12
Financial Highest result since 2018net €2.01M ▲23.7%
Operating result €2.46M, net result €2.01M, both a record.
30-07
State Gazette act Appointment: Jeroen Ingelbrecht (director)
Reappointments: Wim Stragieren (director) and Filip Pauwels (director) · Mandate compensation · Power of attorney9 facts ▸
  • General meeting, 06-06-2024
  • Director appointment, Jeroen Ingelbrecht (director)
  • Director reappointment, Wim Stragieren (director)
  • Director reappointment, Filip Pauwels (director)
  • Mandate compensation, SOLAE BELGIUM
  • Board composition, Wim Stragieren (director)
  • Board composition, Filip Pauwels (director)
  • Board composition, Jeroen Ingelbrecht (director)
  • Power of attorney, DLA Piper UK LLP
28-05
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
12-09
State Gazette act Reappointment: PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: Wouter Coppens2 facts ▸
  • Auditor reappointment, PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Wouter Coppens
06-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
12-07
State Gazette act Reappointments: Filip Pauwels (director) and Wim Stragier (director)
Mandate compensation5 facts ▸
  • General meeting, 16-05-2022
  • Director reappointment, Filip Pauwels (director)
  • Director reappointment, Wim Stragier (director)
  • Mandate compensation, Filip Pauwels
  • Mandate compensation, Wim Stragier
07-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
Show earlier events
2021
31-12
Financial Equity above €25MEq €25.12M ▲4.9%
4 profitable years in a row build equity to €25.12M.
27-05
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
23-12
State Gazette act Resignation: Karin Janssens (director)
Mandate compensation5 facts ▸
  • General meeting, 07-12-2020
  • Director resignation, Karin Janssens (director)
  • Mandate compensation, Karin Janssens
  • Board composition, Wim Stragier (director)
  • Board composition, Filip Pauwels (director)
13-08
State Gazette act Appointment: PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: Wouter Coppens · Mandate compensation6 facts ▸
  • General meeting, 11-06-2020
  • Auditor appointment, PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Wouter Coppens
  • Mandate compensation, Filip Pauwels
  • Mandate compensation, Wim Stragier
  • Mandate compensation, Karin Janssens
12-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
05-06
State Gazette act Capital & shares
Capital decrease · Capital · Reserve release6 facts ▸
  • General meeting, 02-06-2020
  • Capital decrease, €6.210.662,75
  • Capital, €20.096.467,41
  • Reserve release, Beschikbare reserves
  • Power of attorney, AD-MINISTERIE
  • Repayment condition, terugbetaling pas effectief na twee maanden vanaf de bekendmaking van het besluit tot vermindering van het kapitaal in de Bijlagen bij het Belgisch Staatsblad
14-04
State Gazette act Statutes amendment · Miscellaneous
Statutes amendment · Capital3 facts ▸
  • General meeting, 06-04-2020
  • Statutes amendment
  • Capital, €26.307.130,16
05-02
State Gazette act Resignation: Yves Goemans (bestuurder)
Appointment: Karin Janssens (director) · Permanent representative: Wouter Coppens · Mandate compensation16 facts ▸
  • General meeting, 25-11-2019
  • Director resignation, Yves Goemans ((gedelegeerd) bestuurder)
  • Mandate compensation, Yves Goemans
  • Director appointment, Karin Janssens (director)
  • Mandate compensation, Karin Janssens
  • Board composition, Karin Janssens (director)
  • Board composition, Filip Pauwels (director)
  • Board composition, Wim Stragier (director)
  • General meeting, 15-05-2019
  • Permanent representative, Wouter Coppens
  • Mandate compensation, Yves Goemans
  • Board meeting, 08-01-2020
  • +4 further facts in this act
2019
24-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
13-02
State Gazette act Resignation: Sabine Ruys (director)
Appointment: Filip Hendrik Pauwels (director) · Mandate compensation8 facts ▸
  • General meeting, 05-10-2018
  • Director resignation, Sabine Ruys (director)
  • Mandate compensation, Sabine Ruys
  • Director appointment, Filip Hendrik Pauwels (director)
  • Mandate compensation, Filip Hendrik Pauwels
  • Board composition, Yves Goemans (director)
  • Board composition, Wim Stragier (director)
  • Board composition, Filip Hendrik Pauwels (director)
2018
29-06
State Gazette act Reappointment: Yves Goemans (managing director)
Mandate compensation3 facts ▸
  • General meeting, 15-05-2018
  • Director reappointment, Yves Goemans (managing director)
  • Mandate compensation, Yves Goemans
06-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
24-10
State Gazette act Resignation: Mario Treinen (director)
Appointment: Sabine Ruys (director) · Mandate compensation8 facts ▸
  • General meeting, 13/09/2017
  • Director resignation, Mario Treinen (director)
  • Mandate compensation, Mario Treinen
  • Director appointment, Sabine Ruys (director)
  • Mandate compensation, Sabine Ruys
  • Board composition, Yves Goemans (director)
  • Board composition, Wim Stragier (director)
  • Board composition, Sabine Ruys (director)
18-09
State Gazette act Appointments: M. Treinen (director) and BCVBA PwC Bedrijfsrevisoren (statutory auditor)
Reappointment: Y. Goemans (director and managing director) · Permanent representative: Peter Opsomer5 facts ▸
  • General meeting, 22-05-2017
  • Director appointment, M. Treinen (director)
  • Director reappointment, Y. Goemans (director and managing director)
  • Auditor appointment, BCVBA PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Peter Opsomer
19-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
12-05
State Gazette act Resignation: Christelle Van de Steene (director)
Appointment: Wim Jozef Stragier (director) · Mandate compensation4 facts ▸
  • General meeting, 19-04-2017
  • Director resignation, Christelle Van de Steene (director)
  • Director appointment, Wim Jozef Stragier (director)
  • Mandate compensation, Wim Jozef Stragier
2016
29-06
State Gazette act Reappointments: C. Van de steene, M. Treinen and Y. Goemans
Mandate compensation · Mandate term7 facts ▸
  • General meeting, 17-05-2016
  • Director reappointment, C. Van de steene (director)
  • Director reappointment, M. Treinen (director)
  • Director reappointment, Y. Goemans (bestuurder en afgevaardigde bestuurder)
  • Mandate compensation, Solae Belgium
  • Mandate term, tot de volgende Gewone Algemene Vergadering
  • Mandate term, eindigt op de jaarvergadering der Aandeelhouders die zal plaatsvinden in 2017
2015
06-07
State Gazette act Reappointments: C. Van de Steene, M. Treinen and Y. Goemans
Mandate compensation · Mandate term · Auditor mandate end7 facts ▸
  • General meeting, 15-05-2015
  • Director reappointment, C. Van de Steene (director)
  • Director reappointment, M. Treinen (director)
  • Director reappointment, Y. Goemans (bestuurder en afgevaardigde bestuurder)
  • Mandate compensation, Solae Belgium
  • Mandate term, tot de volgende Gewone Algemene Vergadering
  • Auditor mandate end, 2017
2014
23-09
State Gazette act Resignation: Peter Accou (director)
Appointment: Mario Treinen (director) · Mandate compensation4 facts ▸
  • General meeting, 03-09-2014
  • Director resignation, Peter Accou (director)
  • Director appointment, Mario Treinen (director)
  • Mandate compensation, Mario Treinen
10-07
State Gazette act Reappointments: C. Van de Steene, P. Accou and Yves Goemans
Appointment: PwC Bedrijfsrevisoren bcvba (company auditor) · Mandate compensation · Mandate term12 facts ▸
  • General meeting, 15-05-2014
  • Director reappointment, C. Van de Steene (director)
  • Director reappointment, P. Accou (director)
  • Director reappointment, Yves Goemans (director)
  • Director reappointment, Yves Goemans (afgevaardigde bestuurder)
  • Mandate compensation, C. Van de Steene
  • Mandate compensation, P. Accou
  • Mandate compensation, Yves Goemans
  • Mandate term, tot de volgende Gewone Algemene Vergadering
  • Mandate term, tot de volgende Gewone Algemene Vergadering
  • Mandate term, tot de volgende Gewone Algemene Vergadering
  • Auditor appointment, PwC Bedrijfsrevisoren bcvba (company auditor)
2013
05-07
State Gazette act Reappointments: C. Van de Steene, P. Accou and Y. Goemans
Mandate compensation · Mandate term7 facts ▸
  • General meeting, 15-05-2013
  • Director reappointment, C. Van de Steene (director)
  • Director reappointment, P. Accou (director)
  • Director reappointment, Y. Goemans (bestuurder en afgevaardigde bestuurder)
  • Mandate compensation, Solae Belgium
  • Mandate term, tot de volgende Gewone Algemene Vergadering
  • Mandate term, eindigt op de jaarvergadering die zal plaatsvinden in 2014
2012
07-11
State Gazette act Resignation: R. Van Raebroeckx (director)
Appointment: Peter Accou (director) · Mandate compensation · Mandate term5 facts ▸
  • General meeting, 28-08-2012
  • Director resignation, R. Van Raebroeckx (director)
  • Director appointment, Peter Accou (director)
  • Mandate compensation, Peter Accou
  • Mandate term, tot de gewone algemene vergadering van 2013
03-07
State Gazette act Reappointments: C. Van de Steene, R. Van Raebroeckx and Y. Goemans
Mandate compensation · Mandate term · Auditor mandate term8 facts ▸
  • General meeting, 15-05-2012
  • Director reappointment, C. Van de Steene (director)
  • Director reappointment, R. Van Raebroeckx (director)
  • Director reappointment, Y. Goemans (director)
  • Director reappointment, Y. Goemans (afgevaardigde bestuurder)
  • Mandate compensation, Solae Belgium
  • Mandate term, tot de volgende Gewone Algemene Vergadering
  • Auditor mandate term, 2014
2011
08-07
State Gazette act Reappointments: C. Van de Steene, R. Van Raebroeckx and Y. Goemans
Mandate compensation · Mandate term6 facts ▸
  • General meeting, 16-05-2011
  • Director reappointment, C. Van de Steene (director)
  • Director reappointment, R. Van Raebroeckx (director)
  • Director reappointment, Y. Goemans (bestuurder en afgevaardigde bestuurder)
  • Mandate compensation, SOLAE BELGIUM
  • Mandate term, tot de volgende Gewone Algemene Vergadering
14-04
State Gazette act Resignation: N. Dickel (director)
Appointment: Christelle Van de Steene (director) · Mandate compensation · Mandate term5 facts ▸
  • General meeting, 15-03-2011
  • Director resignation, N. Dickel (director)
  • Director appointment, Christelle Van de Steene (director)
  • Mandate compensation, Christelle Van de Steene
  • Mandate term, tot de gewone algemene vergadering van 2011
31-01
State Gazette act Reappointments: N. Dickel, R. Van Raebroeckx and Y. Goemans
Mandate compensation · Mandate term6 facts ▸
  • General meeting, 15-05-2010
  • Director reappointment, N. Dickel (director)
  • Director reappointment, R. Van Raebroeckx (director)
  • Director reappointment, Y. Goemans (bestuurder en afgevaardigde bestuurder)
  • Mandate compensation, SOLAE BELGIUM
  • Mandate term, tot de volgende Gewone Algemene Vergadering
2006
12-06
State Gazette act Reappointments: K. Denoo, N. Dickel and Y. Goemans
Mandate compensation · Mandate term6 facts ▸
  • General meeting, 15-05-2006
  • Director reappointment, K. Denoo (director)
  • Director reappointment, N. Dickel (director)
  • Director reappointment, Y. Goemans (afgevaardigde bestuurder)
  • Mandate compensation, Solae Belgium
  • Mandate term, tot de volgende Gewone Algemene Vergadering
2005
07-11
State Gazette act Capital & shares · Statutes amendment
Capital decrease · Power of attorney4 facts ▸
  • Capital decrease, €26.307.130,16
  • Power of attorney, Jean-Luc INDEKEU
  • Power of attorney, David Richelle
  • Power of attorney, Eric Darc
2004
11-10
State Gazette act Reappointments: J. Gryspeert, N. Dickel and 2 others
Resignations: J. Cadillac (director) and J. Gryspeert (director) · Appointment: Koen Denoo (director) · Mandate compensation21 facts ▸
  • General meeting, 28-07-2003
  • Director reappointment, J. Gryspeert (director)
  • Director reappointment, N. Dickel (director)
  • Director reappointment, J. Cadillac (director)
  • Director reappointment, Y. Goemans (afgevaardigd bestuurder)
  • Mandate compensation, J. Gryspeert
  • Mandate compensation, N. Dickel
  • Mandate compensation, J. Cadillac
  • Mandate compensation, Y. Goemans
  • General meeting, 20-08-2004
  • Director reappointment, J. Gryspeert (director)
  • Director reappointment, N. Dickel (director)
  • +9 further facts in this act
02-02
State Gazette act Registered office · Capital & shares
Capital · Name change · Registered-office move4 facts ▸
  • Capital, €36.307.130,16
  • Name change, SOLAE BELGIUM
  • Registered-office move, 8900 leper, Zwaanhofweg 1
  • Statutes amendment
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
11 directors, no change since 2025
Laszlo Karger-Kocsis
Director · since 14-03-2025
Current
Filip Pauwels
Director · since 28-05-2024
Current
Jeroen Ingelbrecht
Director · since 28-05-2024
Current
Wim Stragieren
Director · since 28-05-2024
Current
Filip Hendrik Pauwels
Director · since 05-10-2018
Not recently confirmed
M. Treinen
Director · since 22-05-2017
Not recently confirmed
5 other directors
Y. Goemans
Director and managing director · since 28-07-2003
Not recently confirmed
Not recently confirmed
P. Accou
Director
Not recently confirmed
K. Denoo
Director
Not recently confirmed
Koen Denoo
Director · since 01-09-2004
Not recently confirmed
14-03-2025 Laszlo Karger-Kocsis: Appointed as Director
14-03-2025 STRAGIER Wim, Jozef: Resigned as Director
28-05-2024 Filip Pauwels: Mandate renewed as Director
28-05-2024 Jeroen Ingelbrecht: Appointed as Director
28-05-2024 Wim Stragieren: Mandate renewed as Director
Full history in the Timeline (29 changes) →
Location & real-estate footprint
Registered office, Ieper · 1 establishment unit since 1977
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Zwaanhofweg 18900 Ieper
Ground area
18.6 ha
Building footprint
9,210 m²
Volume, LiDAR
79,365 m³
Parcel 33305B0964/00D000, Flanders · tallest building 44.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Zwaanhofweg 1, 8900 Ieper
NACE 15880
since 19772.013.392.475
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
33305B0964/00D000 Flanders 18.6 ha 1 · 9,210 m² 44.9 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
Pwc BedrijfsrevisorenCurrent
Statutory auditor · represented by Wouter Coppens
01-09-2023 → present
Show 2 earlier auditors
PricewaterhouseCoopers Reviseurs d'Entreprises
Statutory auditor · represented by Wouter Coppens
succeeded by Pwc Bedrijfsrevisoren in 2023
11-06-2020 → 01-09-2023
PWC Bedrijfsrevisoren BCVBA
Statutory auditor · represented by Peter Opsomer
succeeded by PricewaterhouseCoopers Reviseurs d'Entreprises in 2020
15-05-2014 → 11-06-2020

Articles of association

Purpose
Het vervaardigen, verwerken, kopen, verkopen van, en in het algemeen, het verhandelen en handeldrijven in om het even welke soort of samenstelling van proteïneprodukten, hetzij…
Full purpose

Het vervaardigen, verwerken, kopen, verkopen van, en in het algemeen, het verhandelen en handeldrijven in om het even welke soort of samenstelling van proteïneprodukten, hetzij voor menselijk of dierlijk verbruik, hetzij voor commercieel of industrieel gebruik, het vervaardigen, aankopen, ontwikkelen, raffineren, verkopen, invoeren, uitvoeren, uitbaten en gebruiken van produkten, grondstoffen, toevoegsels en substanties van om het even welke soort en aard, vereist voor of met betrekking tot het gebruik van proteïneproducten; het oprichten of verbouwen, ingevolge een aannemingsovereenkomst of anderszins van gebouwen, fabrieken of andere structuren voor de productie, het gebruik, de formulering of andere behandeling van proteïneproducten, alsmede het maken van offertes en ramingen voor het oprichten van dergelijke gebouwen en het verrichten van alle handelingen die gewoonlijk door bouwaannemers verricht worden; het aankopen en verkopen van bouwmaterialen, uitrusting en andere voorzieningen en het afsluiten van overeenkomsten met het oog op om het even welke der hoger aangegeven doelstellingen, het verlenen van technische bijstand, engineering, know-how, wetenschappelijk en laboratorium-diensten; het optreden als raadgever, manager of consulent; het oprichten van laboratoria, het verrichten van onderzoek en research; het aangaan van verbintenissen voor het verlenen van diensten en adviezen en in het algemeen, het verlenen van zulke diensten en het stellen van die handelingen welke zullen betrekking hebben op de vervaardiging, verkoop of gebruik van proteïneproducten. In het algemeen, mag de vennootschap alle commerciële, industriële en financiële, roerende en onroerende verrichtingen uitvoeren die rechtstreeks of onrechtstreeks verband houden met haar voorwerp, met inbegrip van, maar niet beperkt tot het wetenschappelijk onderzoek en de technische ontwikkeling leasing, het verkrijgen, bezitten, verlenen en gebruiken, onder welke vorm ook, van licenties, brevetten en know-how. De vennootschap zal de leiding en het toezicht kunnen uitoefenen over, en advies verschaffen aan verwante maatschappijen en dochterondernemingen; de vennootschap mag zich bij wijze van inbreng in speciën of in natura, samensmelting, onderschrijving, deelneming, financiële tussenkomst of anderszins, interesseren in andere bestaande of op te richten vennootschappen of ondernemingen, in België of in het buitenland, waarvan het voorwerp verwant of analoog is met het hare of van aard haar voorwerp te bevorderen.

Structure & network

Connections & network

5 connected companies

Capital and shareholders

Capital over the years
  1. 05-06-2020 Capital reduction of 6,210,662.75 EUR · to 20,096,467.41 EUR · repaid to the shareholders
  2. 14-04-2020 Capital stated in the act · 26,307,130.16 EUR · 1,464,626 shares
  3. 07-11-2005 Capital reduction · to 26,307,130.16 EUR
  4. 02-02-2004 Capital stated in the act · 36,307,130.16 EUR

Public money · subsidies and aid

Flemish government

2022 to 2023 · 2 entries · 10,650 EUR awarded · 10,650 EUR paid
Year Entries awardedpaid
2023 1 5,133 EUR5,133 EUR
2022 1 5,517 EUR5,517 EUR
Schemes
Vlaams opleidingsverlof (VOV)
2 entries · 10,650 EUR · 10,650 EUR paid · Departement Werk en Sociale Economie

Recognitions · licences · registrations

Food safety, FASFC

1 site
Ieper2.013.392.475
3 permissions
Fabrikant andere meststoffen · since 17-07-2007
Fabrikant voedermiddelen · since 17-07-2007
Toelating · Fabrikant andere producten plantaardige · since 01-01-2006

Legal Entity Identifier

5493006HR6M5KRM8LU65
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 395 companies in sector 10890 we hold annual accounts for 225. 55 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded01-02-1977
Fiscal year end31-12
Activities, NACEBEL 2025
10890Manufacture of food products
Sources
Crossroads Bank for EnterprisesNational Bank · 52 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.